CaBP4 inhibitors belong to a distinctive chemical class renowned for their ability to modulate the function of the Calcium-Binding Protein 4 (CaBP4), a crucial component in cellular signaling pathways. CaBP4, predominantly found in the retina, plays a pivotal role in regulating the release of neurotransmitters at the synapses between photoreceptor cells and bipolar cells in the eye. This protein is specifically implicated in the modulation of voltage-gated calcium channels, exerting a tight control over the influx of calcium ions and, consequently, influencing synaptic transmission. CaBP4 inhibitors function by disrupting the binding of calcium ions to the CaBP4 protein, thereby impeding its regulatory effects on calcium channels.
The structural diversity of CaBP4 inhibitors allows for a nuanced exploration of their interactions with the target protein. Researchers have synthesized various chemical analogs within this class to decipher the precise molecular determinants governing their inhibitory activity. Understanding the intricate details of the interaction between CaBP4 inhibitors and the target protein enables the design of compounds with enhanced specificity and efficacy. This research not only contributes to the fundamental understanding of calcium signaling in the retina but also holds implications for the development of innovative tools for studying synaptic transmission.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Calcium channel blocker that can reduce calcium influx, modulating CaBP4 action. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Blocks L-type calcium channels, altering calcium signaling affecting CaBP4. | ||||||
Diltiazem | 42399-41-7 | sc-204726 sc-204726A | 1 g 5 g | $209.00 $464.00 | 4 | |
Inhibits calcium ion influx through L-type channels, which can influence CaBP4. | ||||||
Amlodipine | 88150-42-9 | sc-200195 sc-200195A | 100 mg 1 g | $74.00 $166.00 | 2 | |
Selective calcium channel blocker that can alter CaBP4 activity by modulating calcium homeostasis. | ||||||
Nimodipine | 66085-59-4 | sc-201464 sc-201464A | 100 mg 1 g | $61.00 $307.00 | 2 | |
L-type calcium channel blocker that can indirectly affect CaBP4 by altering calcium dynamics. | ||||||
Bepridil | 64706-54-3 | sc-507400 | 100 mg | $1620.00 | ||
Blocks voltage-gated calcium channels, potentially modulating CaBP4 activity. | ||||||
Gabapentin | 60142-96-3 | sc-201481 sc-201481A sc-201481B | 20 mg 100 mg 1 g | $53.00 $94.00 $135.00 | 7 | |
Binds to the auxiliary subunit of voltage-gated calcium channels, possibly influencing CaBP4. | ||||||
Riluzole | 1744-22-5 | sc-201081 sc-201081A sc-201081B sc-201081C | 20 mg 100 mg 1 g 25 g | $20.00 $193.00 $213.00 $317.00 | 1 | |
Modulates glutamatergic signaling and may indirectly affect CaBP4 activity via calcium signaling. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Inhibitor of the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), potentially altering CaBP4 activity due to changes in calcium storage and release. | ||||||